Request Deal Involvement

Novo Holdings led a €90m Series A funding in Orbis Medicines.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Gorrissen Federspiel

legal advisors

Gorrissen Federspiel

or

Principals

ORBIS MEDICINES

target

ORBIS MEDICINES

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

NEW ENTERPRISE ASSOCIATES (NEA)

bidder

NEW ENTERPRISE ASSOCIATES (NEA)

ELI LILLY AND COMPANY

bidder

ELI LILLY AND COMPANY

CORMORANT ASSET MANAGEMENT

bidder

CORMORANT ASSET MANAGEMENT

EXPORT AND INVESTMENT FUND OF DENMARK (EIFO)

bidder

EXPORT AND INVESTMENT FUND OF DENMARK (EIFO)

FORBION CAPITAL PARTNERS

bidder

FORBION CAPITAL PARTNERS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Novo Holdings led a €90m Series A funding in Orbis Medicines.